AEMD
Aethlon Medical IncSubstantial doubt about the company's ability to continue as a going concern.
“management concluded that there were conditions and events which raised substantial doubt as to the Company’s ability to continue as a going concern within twelve months after the date of the issuance of the financial statements included in this Annual Report.”View the 10-K filed Jun 10, 2026
Company with tickers: AEMD
Share-repurchase activity from the company's own XBRL filings — cash spent on equity repurchases (common and preferred combined, as reported) per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2019-03-31 | $193,866 | 10-K, filed 2019-07-01 |
| 2018-03-31 | $278,633 | 10-K, filed 2019-07-01 |
| 2017-03-31 | $378,518 | 10-K, filed 2018-06-08 |
| 2016-03-31 | $0 | 10-K, filed 2017-06-28 |